Randomized Trial of Telehealth vs. Conventional Hearing Care Delivery in the ACHIEVE Study (ACHIEVE Hearing Intervention Follow-Up, or ACHIEVE-HIFU)

Eligibility: Adults aged 70-84 years with hearing loss who were free of cognitive impairment at the start.

Goal: To compare the effect of the telehealth hearing health care (HHC) versus conventional HHC delivery models on hours of hearing aid use, hearing and communication outcomes, social functioning, quality of life, and utilization of services in older adults with hearing loss.   

Contact Information: USF ARCT lab phone at 813-974-1262 or email us at; Mention the "ACHIEVE HIFU”. 


Principal Investigator: Frank R. Lin, M.D., Ph.D. & Victoria Sanchez, Au.D., Ph.D., CCC-A

IRB Number: 00284937 


Study Overview 

ACHIEVE HIFU is a follow up study involving the participants from the ACHIEVE randomized control study. This multi-site randomized trial is investigating how a telehealth hearing health care (HHC) delivery model can impact hearing aid use, communication, and quality of life outcomes of older adult hearing aid users from the ACHIEVE RCT study. Eligibility for the study is the same as the ACHIEVE RCT study. Participants are randomized to telehealth HHC or conventional in-person HHC. The study follows participants for 8 sessions over a 2-year period post ACHIEVE RCT intervention.